- Home
- SCPH vs NB Comparison
SCPH vs NB Comparison
Compare SCPH & NB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCPH
- NB
- Stock Information
- Founded
- SCPH 2013
- NB 1987
- Country
- SCPH United States
- NB United States
- Employees
- SCPH N/A
- NB N/A
- Industry
- SCPH Biotechnology: Pharmaceutical Preparations
- NB Metal Mining
- Sector
- SCPH Health Care
- NB Basic Materials
- Exchange
- SCPH Nasdaq
- NB Nasdaq
- Market Cap
- SCPH 173.6M
- NB 139.3M
- IPO Year
- SCPH 2017
- NB N/A
- Fundamental
- Price
- SCPH $3.84
- NB $2.60
- Analyst Decision
- SCPH Strong Buy
- NB Strong Buy
- Analyst Count
- SCPH 3
- NB 2
- Target Price
- SCPH $14.00
- NB $4.13
- AVG Volume (30 Days)
- SCPH 289.6K
- NB 696.1K
- Earning Date
- SCPH 08-13-2025
- NB 05-08-2025
- Dividend Yield
- SCPH N/A
- NB N/A
- EPS Growth
- SCPH N/A
- NB N/A
- EPS
- SCPH N/A
- NB N/A
- Revenue
- SCPH $41,982,000.00
- NB N/A
- Revenue This Year
- SCPH $108.95
- NB N/A
- Revenue Next Year
- SCPH $73.83
- NB N/A
- P/E Ratio
- SCPH N/A
- NB N/A
- Revenue Growth
- SCPH 138.10
- NB N/A
- 52 Week Low
- SCPH $1.94
- NB $1.27
- 52 Week High
- SCPH $5.65
- NB $4.15
- Technical
- Relative Strength Index (RSI)
- SCPH 56.83
- NB 50.59
- Support Level
- SCPH $3.86
- NB $2.50
- Resistance Level
- SCPH $4.17
- NB $3.10
- Average True Range (ATR)
- SCPH 0.23
- NB 0.18
- MACD
- SCPH -0.06
- NB 0.01
- Stochastic Oscillator
- SCPH 33.33
- NB 32.43
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
About NB NioCorp Developments Ltd.
NioCorp Developments Ltd is engaged in exploration and development of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property.